Log In
BCIQ
Print this Print this
 

CLS-1002

  Manage Alerts
Collapse Summary General Information
Company Clearside Biomedical Inc.
DescriptionSuprachoroidal space injection of axitinib, a dual VEGF and PDGF inhibitor
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationAge-related macular degeneration (AMD)
Indication DetailsTreat wet age-related macular degeneration (AMD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today